CTKB
Price
$5.46
Change
-$0.03 (-0.55%)
Updated
Jan 17 closing price
Capitalization
876.52M
38 days until earnings call
NVCR
Price
$26.17
Change
+$0.15 (+0.58%)
Updated
Jan 17 closing price
Capitalization
1.66B
39 days until earnings call
Ad is loading...

CTKB vs NVCR

Header iconCTKB vs NVCR Comparison
Open Charts CTKB vs NVCRBanner chart's image
Cytek Biosciences
Price$5.46
Change-$0.03 (-0.55%)
Volume$705.64K
Capitalization876.52M
NovoCure
Price$26.17
Change+$0.15 (+0.58%)
Volume$1.18M
Capitalization1.66B
CTKB vs NVCR Comparison Chart
Loading...
CTKB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTKB vs. NVCR commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTKB is a Hold and NVCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CTKB: $5.46 vs. NVCR: $26.17)
Brand notoriety: CTKB and NVCR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CTKB: 109% vs. NVCR: 87%
Market capitalization -- CTKB: $876.52M vs. NVCR: $1.66B
CTKB [@Medical Specialties] is valued at $876.52M. NVCR’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTKB’s FA Score shows that 0 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • CTKB’s FA Score: 0 green, 5 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, NVCR is a better buy in the long-term than CTKB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTKB’s TA Score shows that 3 TA indicator(s) are bullish while NVCR’s TA Score has 3 bullish TA indicator(s).

  • CTKB’s TA Score: 3 bullish, 2 bearish.
  • NVCR’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, CTKB is a better buy in the short-term than NVCR.

Price Growth

CTKB (@Medical Specialties) experienced а -19.94% price change this week, while NVCR (@Medical Specialties) price change was -4.66% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

CTKB is expected to report earnings on May 07, 2025.

NVCR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.66B) has a higher market cap than CTKB($877M). NVCR YTD gains are higher at: -12.181 vs. CTKB (-15.871). CTKB has higher annual earnings (EBITDA): -4.41M vs. NVCR (-177.45M). NVCR has more cash in the bank: 911M vs. CTKB (262M). CTKB has less debt than NVCR: CTKB (14.1M) vs NVCR (596M). NVCR has higher revenues than CTKB: NVCR (509M) vs CTKB (193M).
CTKBNVCRCTKB / NVCR
Capitalization877M1.66B53%
EBITDA-4.41M-177.45M2%
Gain YTD-15.871-12.181130%
P/E Ratio370.37N/A-
Revenue193M509M38%
Total Cash262M911M29%
Total Debt14.1M596M2%
FUNDAMENTALS RATINGS
NVCR: Fundamental Ratings
NVCR
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTKBNVCR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
79%
Momentum
ODDS (%)
Bullish Trend 12 days ago
73%
Bearish Trend 12 days ago
81%
MACD
ODDS (%)
Bullish Trend 12 days ago
70%
Bearish Trend 12 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
77%
Bearish Trend 12 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 17 days ago
76%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
83%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
81%
View a ticker or compare two or three
Ad is loading...
CTKB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EIUTX16.190.13
+0.81%
Eaton Vance Dividend Builder I
EICVX17.330.12
+0.70%
EIC Value A
MIOFX24.920.11
+0.44%
Marsico International Opportunities
JDMRX126.310.14
+0.11%
Janus Henderson Enterprise R
FSRNX16.22N/A
N/A
Fidelity Real Estate Index

CTKB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTKB has been loosely correlated with CRL. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CTKB jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
-0.55%
CRL - CTKB
57%
Loosely correlated
-1.39%
HBIO - CTKB
44%
Loosely correlated
+0.52%
IQV - CTKB
41%
Loosely correlated
-0.15%
FLGT - CTKB
39%
Loosely correlated
-2.29%
MASS - CTKB
38%
Loosely correlated
+2.76%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with FLGT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+0.58%
FLGT - NVCR
41%
Loosely correlated
-2.29%
KIDS - NVCR
39%
Loosely correlated
+2.37%
CTKB - NVCR
36%
Loosely correlated
-0.55%
VCYT - NVCR
35%
Loosely correlated
-1.27%
INMD - NVCR
35%
Loosely correlated
+1.33%
More